NCT03494296View on ClinicalTrials.gov

A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2026

Conditions
Lymphoma
Interventions
DRUG

patients received D-COP regimen chemotherapy

patients received D-COP regimen chemotherapy

Trial Locations (1)

150001

RECRUITING

The First Affiliated Hospital of Harbin Medical University, Department of Hematology, Lymphoma Ward, Harbin

All Listed Sponsors
lead

First Affiliated Hospital of Harbin Medical University

OTHER